Adeona CEO to Present at Medical Technology-Life Sciences Event

-- Event Scheduled for Tuesday, December 7, 2010 in New York City --

Dec 02, 2010, 08:49 ET from Adeona Pharmaceuticals, Inc.

ANN ARBOR, Mich., Dec. 2, 2010 /PRNewswire/ -- Adeona Pharmaceuticals, Inc. (Amex: AEN), a developer of innovative medicines for serious central nervous system diseases, announced today that James S. Kuo, M.D., M.B.A., the Company's Chief Executive Officer, will be a featured presenter at the upcoming Medical Technology-Life Sciences Event.  The event will be held in New York City on December 7, 2010. For complete event details, please visit

About NYC MedTech

NYC MedTech forums are held six times a year and allow companies to present their science and technology in an environment consisting of industry, academia, researchers and talented individuals, as well as investment professionals. In addition, the audience also hears unique, timely and relevant information from the guest speaker presentation.

About Adeona Pharmaceuticals, Inc.

Adeona is a pharmaceutical company developing innovative medicines for the treatment of serious central nervous system diseases. The Company's strategy is to license product candidates that have demonstrated a certain level of clinical efficacy and develop them to a stage that results in a significant commercial collaboration. Currently, Adeona is developing the following product candidates: a prescription medical food for Alzheimer's disease, and drugs for multiple sclerosis, fibromyalgia, rheumatoid arthritis and age-related macular degeneration. For more information, please visit Adeona's website at

SOURCE Adeona Pharmaceuticals, Inc.